GSK reaches up to $2.2 billion settlement in Zantac US state court cases
By Thomson ReutersOct 9, 2024 | 1:50 PM
(Reuters) – GSK said on Wednesday it had reached agreements with ten plaintiff firms, representing 93% of U.S. state court Zantac product liability cases pending against the drugmaker, for up to $2.2 billion.
For the health and safety of everyone, our offices are temporarily closed to the public. If you have won a prize from us we will be mailing it to you or will contact you with specific information needed to redeem your prize. Feel free to call us with questions during weekday business hours at (616) 392-3121.
Comments